GeneReach Biotechnology Corp.
Research GeneReach Biotechnology Corp. (4171.TWO) on Bullrun: market cap TWD 992.16M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4171.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 992.16M
- Financial periodQ2 2026
- RevenueTWD 60.03M
- Net income-TWD 3.88M
- Free cash flow-TWD 1.85M
- Gross margin80.3%
Valuation Snapshot
latest market cap is TWD 992.16M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 992.16M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About GeneReach Biotechnology Corp.
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GeneReach Biotechnology Corp.'s market cap?
GeneReach Biotechnology Corp.'s market capitalization is TWD 992.16M.
What does GeneReach Biotechnology Corp. do?
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ2000 Detection & Prevention System.